Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Misumi

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Journal of Neurology|January 19, 2026
High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort studyShizuka Harada, Makoto Nakajima, Toshiya Nomura, et al.
Cureus|May 7, 2025
Senescence Accelerates the Occurrence of Dual Amyloidosis: Alzheimer's Disease and Wild-Type Transthyretin AmyloidosisYohei Misumi, Yukio Ando, Naoya Nakashima, et al.
Journal of Diabetes Investigation|December 24, 2019
Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two casesTerumasa Nagase, Keiichi Iwaya, Koichiro Kogure, et al.
Japanese Journal of Radiology|November 29, 2021
Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?Hidetaka Hayashi, Seitaro Oda, Masafumi Kidoh, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 2, 2011
Spinal multifocal amyloidosis derived from wild-type transthyretinTakanao Sueyoshi, Mitsuharu Ueda, Akira Sei, et al.
Annals of Clinical Biochemistry|September 6, 2015
Rapid detection of wild-type and mutated transthyretinsMasayoshi Tasaki, Mitsuharu Ueda, Konen Obayashi, et al.
Heliyon|October 25, 2021
Glavonoid, a possible supplement for prevention of ATTR amyloidosisHiroaki Matsushita, Aito Isoguchi, Masamitsu Okada, et al.
Biochemical and Biophysical Research Communications|September 3, 2010
Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanismMasayoshi Tasaki, Mitsuharu Ueda, Sho Ochiai, et al.
Clinical Chemistry|April 18, 2009
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathyMitsuharu Ueda, Yohei Misumi, Mineyuki Mizuguchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2013
Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30MethionineKonen Obayashi, Masayoshi Tasaki, Hirofumi Jono, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Journal of Neurology|January 19, 2026
High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort studyShizuka Harada, Makoto Nakajima, Toshiya Nomura, et al.
Cureus|May 7, 2025
Senescence Accelerates the Occurrence of Dual Amyloidosis: Alzheimer's Disease and Wild-Type Transthyretin AmyloidosisYohei Misumi, Yukio Ando, Naoya Nakashima, et al.
Journal of Diabetes Investigation|December 24, 2019
Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two casesTerumasa Nagase, Keiichi Iwaya, Koichiro Kogure, et al.
Japanese Journal of Radiology|November 29, 2021
Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?Hidetaka Hayashi, Seitaro Oda, Masafumi Kidoh, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 2, 2011
Spinal multifocal amyloidosis derived from wild-type transthyretinTakanao Sueyoshi, Mitsuharu Ueda, Akira Sei, et al.
Annals of Clinical Biochemistry|September 6, 2015
Rapid detection of wild-type and mutated transthyretinsMasayoshi Tasaki, Mitsuharu Ueda, Konen Obayashi, et al.
Heliyon|October 25, 2021
Glavonoid, a possible supplement for prevention of ATTR amyloidosisHiroaki Matsushita, Aito Isoguchi, Masamitsu Okada, et al.
Biochemical and Biophysical Research Communications|September 3, 2010
Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanismMasayoshi Tasaki, Mitsuharu Ueda, Sho Ochiai, et al.
Clinical Chemistry|April 18, 2009
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathyMitsuharu Ueda, Yohei Misumi, Mineyuki Mizuguchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2013
Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30MethionineKonen Obayashi, Masayoshi Tasaki, Hirofumi Jono, et al.
Pageof 14